AMSA is an API manufacturer based in Italy. It holds 6 active US drug master files and 5 valid CEPs across a filed portfolio of 10 molecules. Its filings concentrate with BRELA (TZ) and MINSA (CR).
| Site | FDA FEI |
|---|---|
| - ANONIMA MATERIE SINTETICHE & AFFINI Como, Italy | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Glycopyrronium | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Diclofenac | US FDA | 1 |
| Etodolac | US FDA | 1 |
| Flecainide | EDQM | 1 |
| Glipizide | US FDA | 1 |
| Levodropropizine | EDQM | 1 |
| Lurasidone | US FDA | 1 |
| Meloxicam | EDQM | 1 |
| Metoclopramide | EDQM | 1 |
| Viloxazine | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| BRELA (TZ) | 1 | None |
| MINSA (CR) | 1 | None |
Choose your molecules and target markets. AMSA comes back tiered against every other supplier able to file there.
Start for free